EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Intravenous Tranexamic Acid on Postoperative Complications in Gender-Affirming Mastectomy: A Focus on Drain Output and Duration

Lisa Radacher, Maximilian Zaussinger, Sandra Feldler, Bernhard Schwartz, Manfred Schmidt

Aesthetic Plastic Surgery · 2026-06 · 50 (11) · 4034-4043

DOI: 10.1007/s00266-026-05797-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aesthetic Plastic Surgery, online erschienen am 17.03.2026. Verfasst von Lisa Radacher und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, Johannes Kepler University Linz, Altenbergerstr. 69, 4040, Linz, Austria. Hauptthemen laut MEDLINE: Tranexamic Acid, Mastectomy, Gender-Affirming Surgery, Antifibrinolytic Agents. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johannes Kepler University Linz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tranexamic acid (TXA) has been increasingly acknowledged as a beneficial pharmacological agent in plastic surgery. However, despite its proven efficacy and safety, there is limited research on its intravenous application in gender-affirming mastectomy, particularly regarding its effect on drain duration, drain output, and length of hospital stay.

Methods

In this retrospective single-center study, patients who underwent double incision mastectomy with free nipple grafts were categorized into two cohorts: one group receiving TXA and a control group without TXA utilization (TXA vs no-TXA). Demographic characteristics, surgical data, and complication rates were analyzed and compared.

Results

A total of 75 patients were included, with 34 procedures performed without the administration of TXA and 41 patients receiving TXA. The median age of the study population was 24 years (range 18–57). Postoperative bleeding requiring surgical revision was significantly less frequent in the TXA group ( p = 0.038). Total drain output ( p = 0.048), drain duration ( p < 0.001) and length of hospital stay ( p = 0.008) were significantly reduced in the TXA group. No thromboembolic events or seizures were observed.

Conclusions

This study demonstrated that intravenously administered TXA significantly reduces the incidence of postoperative hematoma, length of hospital stay, drain duration, and output after gender-affirming mastectomy. Based on these findings, we would recommend the use of TXA in double incision mastectomy with free nipple grafts to minimize the occurrence of seroma formation and major bleeding-related complications. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidMastectomyGender-Affirming SurgeryAntifibrinolytic AgentsPostoperative ComplicationsHumansFemaleRetrospective StudiesDrainageAdultMiddle AgedTreatment OutcomeAdolescentLength of StayYoung AdultRisk AssessmentCohort StudiesTime FactorsFollow-Up StudiesAdministration, Intravenous

Stichwörter der Autor:innen

Drain durationDrain outputGender-affirming mastectomyHematomaTranexamic acid

Substanzen

Tranexamic AcidAntifibrinolytic Agents

Autor:innen und Institutionen

  • Medical Faculty, Johannes Kepler University Linz, Altenbergerstr. 69, 4040, Linz, Austria.
  • Medical Faculty, Johannes Kepler University Linz, Altenbergerstr. 69, 4040, Linz, Austria. m.zaussinger@hotmail.com.
  • Department of Plastic, Aesthetic and Reconstructive Surgery, Kepler University Hospital, Krankenhausstr. 9, 4020, Linz, Austria. m.zaussinger@hotmail.com.
  • Department of Plastic, Aesthetic and Reconstructive Surgery, Kepler University Hospital, Krankenhausstr. 9, 4020, Linz, Austria.
  • Department of Research and Development, University of Applied Sciences for Health Professions Upper Austria, Semmelweisstr. 34/D3/2, 4020, Linz, Austria.

Förderung

  • Johannes Kepler University Linz

Zitieren

APA

Radacher, L., Zaussinger, M., Feldler, S., Schwartz, B., & Schmidt, M. (2026). Impact of Intravenous Tranexamic Acid on Postoperative Complications in Gender-Affirming Mastectomy: A Focus on Drain Output and Duration. Aesthetic Plastic Surgery, 50(11), 4034-4043. https://doi.org/10.1007/s00266-026-05797-0

Vancouver

Radacher L, Zaussinger M, Feldler S, Schwartz B, Schmidt M. Impact of Intravenous Tranexamic Acid on Postoperative Complications in Gender-Affirming Mastectomy: A Focus on Drain Output and Duration. Aesthetic Plastic Surgery. 2026;50(11):4034-4043. doi:10.1007/s00266-026-05797-0

BibTeX
@article{Radacher2026,
  author = {Radacher, Lisa and Zaussinger, Maximilian and Feldler, Sandra and Schwartz, Bernhard and Schmidt, Manfred},
  title = {Impact of Intravenous Tranexamic Acid on Postoperative Complications in Gender-Affirming Mastectomy: A Focus on Drain Output and Duration},
  journal = {Aesthetic Plastic Surgery},
  year = {2026},
  volume = {50},
  number = {11},
  pages = {4034--4043},
  doi = {10.1007/s00266-026-05797-0}
}
Kostenlos starten →